Astria Therapeutics Inc. buy BiotechBee
Start price
20.07.23
/
60%
€8.86
Target price
30.04.26
€10.00
Performance (%)
3.84%
End price
14.12.24
€9.20
Summary
This prediction ended on 14.12.24 with a price of €9.20. With a performance of 3.84%, the BUY prediction by BiotechBee for Astria Therapeutics Inc. closed with a slight gain. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Astria Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
According to BiotechBee what are the pros and cons of Astria Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Astria Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Astria Therapeutics Inc.
Buy beendet

